ACTRN12617001233314
Recruiting
N/A
An investigation into the clinical effectiveness and cost benefit of an intensive therapeutic lifestyle intervention for people with Type 2 Diabetes.
Avondale College of Higher Education0 sites150 target enrollmentAugust 23, 2017
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Type 2 Diabetes Mellitus
- Sponsor
- Avondale College of Higher Education
- Enrollment
- 150
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •A current diagnosis of Type 2 Diabetes Mellitus
- •Over the age of 18 years
Exclusion Criteria
- •Persons will be ineligible for the study if:
- •a.they are aged less than 18 years
- •b.the consulting medical practitioner considers that an alteration in nutrient or calorie consumption or that the participating in regular moderate exercise could result in an increased health risk. This may include but may not be limited to:
- •i. persons having a history of uncontrolled hypertension with consistent resting blood pressure readings greater than 180mmHg systolic and or greater than 110 mm Hg diastolic;
- •ii.persons having a BMI lower than 21 kg/m²; and making use of weight\-loss medication;
- •iii.persons experiencing recurrent chest pain or unstable angina;
- •iv.pregnant or lactating females, or females planning to become pregnant in the next year;
- •v.persons having undergone angioplasty or having had a myocardial infarction or cardiac surgery within the previous 3 months;
- •c. they have any condition that precludes the potential participant from increasing their level of physical activity;
- •d..they have any physical condition or language barrier that would preclude them from understanding or safely adopting the lifestyle changes recommended by the CHIP intervention.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
A study to assess the clinical effectiveness and safety of intravesical mitomycin-C and gemcitabine sequential therapy in patients with high risk non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG) Therapy: Prospective, multicenter, open-label trialKCT0009491ational Cancer Center82
Active, Not Recruiting
N/A
The clinical efficiency of positive airway pressure (PAP) treatment in patients with moderate-severe obstructive sleep apnea syndrome (OSAS)Obstructive sleep apneaRespiratory - Sleep apnoeaACTRN12613000373774Sabri Koseoglu75
Not Yet Recruiting
Phase 3
Study on using inheritance characters test for medication in new schizophrenia patients in northern India to enhance treatment effectivenessCTRI/2024/06/069270Dr Amrita Kumari Pandey
Recruiting
N/A
A clinical study to evaluate the effectiveness and safety of HJHP on cognitive function improvementKCT0008744Ewha Womens University80
Recruiting
Phase 4
Effectiveness of the Homoeopathic Medicine Ipecac in Chronic CoughCTRI/2024/01/062140VINAYAKA MISSION HOMOEOPATHY MEDICAL COLLEGE AND HOSPITA